Pyrosequencing™-based screening for the genetic polymorphism CYP2B6 1459 C>T

被引:0
|
作者
Doehring, Alexandra [1 ]
Loetsch, Joern [1 ]
机构
[1] Goethe Univ Frankfurt, Pharmazentrum Frankfurt ZAFES, Inst Clin Pharmacol, D-60590 Frankfurt, Germany
关键词
CYTOCHROME P4502B6; THERAPY;
D O I
10.2217/PGS.09.123
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:1577 / 1579
页数:3
相关论文
共 50 条
  • [21] Genetic variability (785A > G, 516G > T and 64C > T) in the CYP2B6 gene among individuals in Southwest Nigeria: Implications for malaria treatment
    Bamikole, Oluwayemi J.
    Ademola, Subulade A.
    Agatha-Christie, Dibia
    Yellow, Sandy Imo
    Etim, Joshua
    Ajige, Abdul-Lucky
    Amodu, Olukemi K.
    HUMAN GENE, 2022, 34
  • [22] Promoter region polymorphism of CYP11B2 (344 C>T) gene in healthy volunteers of South Indian Tamilian population
    Rajan, S.
    Ramu, P.
    Shewade, D. G.
    Adithan, C.
    INDIAN JOURNAL OF BIOTECHNOLOGY, 2009, 8 (04): : 358 - 362
  • [23] Impact of the Cytochrome P450 2B6 (CYP2B6) Gene Polymorphism c.516G>T (rs3745274) on Propofol Dose Variability
    Mourao, Artemisia L.
    de Abreu, Fabiana G.
    Fiegenbaum, Marilu
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2016, 41 (05) : 511 - 515
  • [24] Efavirenz and CYP2B6 polymorphism:: Implications for drug toxicity and resistance
    Nolan, D
    Phillips, E
    Mallal, S
    CLINICAL INFECTIOUS DISEASES, 2006, 42 (03) : 408 - 410
  • [25] ROLE OF CYP2B6 POLYMORPHISM IN THE METABOLISM AND PHARMACOKINETICS OF METHADONE ENANTIOMERS
    Somogyi, A. A.
    Coller, J. K.
    Foster, D. B. F.
    Li, Y.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 32 - 32
  • [26] Impact of CYP2B6 polymorphism on hepatic efavirenz metabolism in vitro
    Desta, Zeruesenay
    Saussele, Tanja
    Ward, Bryan
    Blievernicht, Julia
    Li, Lang
    Klein, Kathrin
    Flockhart, DavidA
    Zanger, Ulrich M.
    PHARMACOGENOMICS, 2007, 8 (06) : 547 - 558
  • [27] Pharmacokinetics of Plasma Efavirenz and CYP2B6 Polymorphism in Southern Chinese
    To, Kin Wang
    Liu, Shui Teng
    Cheung, Siu Wai
    Chan, D. Pui Chung
    Chan, R. Chiu Yeung
    Lee, Shui Shan
    THERAPEUTIC DRUG MONITORING, 2009, 31 (04) : 527 - 530
  • [28] Molecular simulation study of CYP2B6 polymorphism with and without psoralen
    Lu, Nan
    Meng, Fancui
    Xu, Weiren
    Tang, Lida
    Xu, Youjun
    MOLECULAR SIMULATION, 2018, 44 (17) : 1402 - 1410
  • [29] Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver
    Lang, T
    Klein, K
    Fischer, J
    Nüssler, AK
    Neuhaus, P
    Hofmann, U
    Eichelbaum, M
    Schwab, M
    Zanger, UM
    PHARMACOGENETICS, 2001, 11 (05): : 399 - 415
  • [30] Hemolysis and Mediterranean G6PD mutation (c.563 C>T) and c.1311 C>T polymorphism among Palestinians at Gaza Strip
    Sirdah, Mahmoud
    Reading, N. Scott
    Perkins, Sherrie L.
    Shubair, Mohammad
    Aboud, Lina
    Prchal, Josef T.
    BLOOD CELLS MOLECULES AND DISEASES, 2012, 48 (04) : 203 - 208